Back

Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention

European Heart Journal

27 February 2021
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY Interventional Cardiology BASIC SCIENCE BASICS Pharmacology and Pharmacotherapy

Contributors

Davide Cao
Davide Cao

Author

Humanitas University Milan , Italy

Usman Baber
Usman Baber

Author

Roxana Mehran
Roxana Mehran

Author

Icahn School of Medicine at Mount Sinai New York City , United States of America

You may be interested in
thumbnail
Congress Presentation
Antiplatelet strategies
26 March 2023
thumbnail
Congress Presentation
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients (LEGACY)
1 September 2025
thumbnail
Congress Presentation
Optimizing antiplatelet therapy in ACS: a network meta-analysis of simplified regimens
1 September 2025
thumbnail
Congress Presentation
Comparative efficacy of clopidogrel and aspirin monotherapy after dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources